NIVEN RALPH

CIK 00011680602 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001168060

Recent Transactions

50 trades

Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-02-05−500→ 10,894 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-02-05−1,500→ 41,732 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-02-05$1.74/sh+1,400→ 3,009 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-02-05−500→ 9,088 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-02-05$2.14/sh+3,200→ 6,209 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-02-05−900→ 13,308 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-02-05$17.45/sh−4,600→ 1,609 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-02-05−1,200→ 34,908 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-01-22+66,586→ 66,586 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-01-05$1.74/sh+1,400→ 3,009 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-01-05$18.67/sh−2,126→ 4,083 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-01-05−900→ 14,208 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-01-05−1,500→ 43,232 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-01-05−500→ 11,394 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-01-05$19.57/sh−2,474→ 1,609 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-01-05−500→ 9,588 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-01-05$2.14/sh+3,200→ 6,209 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-01-05−1,200→ 36,108 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-05−900→ 15,108 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-05−500→ 11,894 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2023-12-05$16.30/sh−4,600→ 1,609 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-05−500→ 10,088 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-05−1,200→ 37,308 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-05−1,500→ 44,732 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-12-05$1.74/sh+1,400→ 3,009 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-12-05$2.14/sh+3,200→ 6,209 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-22−4,500→ 46,232 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2023-11-22$15.00/sh−13,800→ 1,609 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-22−2,700→ 16,008 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-11-22$1.74/sh+4,200→ 5,809 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-22−3,600→ 38,508 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-11-22$2.14/sh+9,600→ 15,409 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-22−1,500→ 12,394 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-22−1,500→ 10,588 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-07-05−650→ 42,108 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-07-05$2.14/sh+1,600→ 3,859 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-07-05−450→ 18,708 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2023-07-05$17.23/sh−2,031→ 1,828 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-07-05−200→ 12,088 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2023-07-05$17.87/sh−219→ 1,609 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-07-05−750→ 50,732 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-07-05$1.74/sh+650→ 2,259 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-07-05−200→ 13,894 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-06-05−650→ 42,758 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-06-05$2.14/sh+1,600→ 3,859 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-06-05−200→ 12,288 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-06-05−450→ 19,158 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2023-06-05$16.26/sh−2,250→ 1,609 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-06-05−200→ 14,094 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-06-05$1.74/sh+650→ 2,259 total

Companies

Recent Filings

Address

C/O AEROVATE THERAPEUTICS, INC. 200 BERKELEY STREET, FLOOR 18

BOSTON, MA, 02116

View on SEC.gov